Site icon OncologyTube

RECOURSE trial compared to CORRECT and CONCUR evaluating regorafenib in mCRC

Axel Grothey, MD of Mayo Clinic discusses the RECOURSE trial compared to CORRECT and CONCUR evaluating regorafenib in mCRC at ASCO GI 2016

Exit mobile version